Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities of continuing operations:
Net income (loss)	$ (1,643,639)	$ (1,091,122)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	222,428	200,101
Amortization of debt discount	147,875	152,797
Common stock issued in exchange for fees and services	349,645	66,375
Deferred taxes	(2,658)	6,709
Stock-based compensation	16,200	76,193
Loss on extinguishment of debt	363,468	0
Changes in operating assets and liabilities:
Accounts receivable	366,631	(192,917)
Inventory	517	15,869
Prepaid expenses and other current assets	(138,456)	174,559
Operating lease right of use assets	5,548	0
Other assets	40,237	2,711
Accounts payable	(16,126)	(153,448)
Accrued liabilities	5,678	48,999
Advanced payments and deferred revenues	(75,197)	(185,429)
Income taxes payable and other noncurrent liabilities	(38,705)	(9,481)
Related party payables	(154,216)	387,321
Net cash provided by (used in) operating activities	(550,770)	(500,763)
Cash flows from investing activities:
Purchase of fixed assets	(105,241)	(170,921)
Net cash provided by (used in) investing activities	(105,241)	(170,921)
Cash flows from financing activities:
Proceeds from issuance of preferred stock, net of issuance costs	356,395	0
Proceeds from issuance of common stock, net of issuance costs	443,605	0
Proceeds from exercise of common stock purchase warrants, net of issuance costs	0	61,500
Proceeds from issuance of convertible debentures	0	671,760
Repayments of convertible debentures	(26,286)	(50,000)
Net cash provided by (used in) financing activities	773,714	683,260
Effect of exchange rates on cash and cash equivalents	11,204	(41,595)
Net increase (decrease) in cash and cash equivalents	128,907	(30,019)
Cash and cash equivalents at beginning of the period	633,593	436,869
Cash and cash equivalents at end of the period	762,500	406,850
Supplemental disclosure of cash flow information:
Cash paid for interest	67,703	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued for financing costs incurred in connection with convertible and promissory notes	0	589,839
Common stock issued in connection with long term service contracts	0	72,000
Common stock issued to reduce convertible and promissory notes payable	0	171,376
Common stock issued to reduce accounts payable and other accrued liabilities	26,940	0
Discount for beneficial conversion features on convertible debentures	$ 0	$ 801